Clinical Trial Details
EORTC-55051
Back to Clinical Trials Database
A multi-national randomized Phase III GCIG Intergroup Study comparing Pegylated Liposomal Doxorubicin and Carboplatin (CaC) versus Paclitaxel and Carboplatin (TC) in patients with epithelial ovarian cancer in late relapse (>6 months).
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 28-Sep-2006 Date Step1 close: 25-Sep-2007 |
| Data management at EORTC | No |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 570 - All Groups: 800 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number | |
| EudraCT | 2004-004456-39 |
